A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PAC / plasma aldosterone concentration

[Related PubMed/MEDLINE]
Total Number of Papers: 460
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PAC  (>> Co-occurring Abbreviation)
Long Form:   plasma aldosterone concentration
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism. AUC, CCT, FST, PA, SIT
2020 Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism. APAs, AVS, CSI, LI, PA, ROC, SIT
2020 Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma. APA, ARC, ARR, eGFR, POM
2020 Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS. FST, PA, PACIA, ROC, SSST
2020 Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals. CH, EH-CPSS, PH, PHPV, PRA, RAAS
2020 The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism. ARR, eGFR, PA, PRA, ROC
2019 Association of Papillary Thyroid Carcinoma with Primary Aldosteronism. BP, PA, PC, PRA
2019 Association of the plasma aldosterone concentration, left atrial deformation and ambulatory blood pressure in never-treated early hypertensive patients. ABPM, BP, GLS, LA, LV, RAAS
2019 Diagnostic Accuracy of the Aldosterone-to-Active Renin Ratio for Detecting Primary Aldosteronism. AARR, PA, ROC, SIT
10  2019 Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test. APA, AVS, PA, ROC
11  2019 Evaluation of Biochemical Conditions Allowing Bypass of Confirmatory Testing in The Workup of Primary Aldosteronism: A Retrospective Study in a French Hypertensive Population. ARR, CCT, IA, SIT
12  2019 Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value. ADRR, ARR, CLIA, DRC, PA, PH, PRA, RIA
13  2019 High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan. PA, SH
14  2019 Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study. LRH, PA, PRA, SIT
15  2019 P-glycoprotein influences urinary excretion of aldosterone in healthy individuals. P-gp
16  2019 Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism. APA, CT, PA, SIT, TAIPAI
17  2019 Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study. APA, ARR, baPWV, EHT, IHA, LVMI, PA, PRA, SHRIMP
18  2019 Primary aldosteronism in Klinefelter's syndrome: two cases. APA, AVS, LH, PA
19  2019 Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. eGFR, EHT, JPAS, PA
20  2019 Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism. AVS, CCT, PA
21  2019 Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals. ABI, CIMT, SUA, UAE
22  2019 The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population. ARR, CCT, PA, PH, RAS
23  2019 The characteristics of captopril challenge test-positive patients using various criteria. ARR, CCT, PA
24  2019 The Differential Effect of Excess Aldosterone on Skeletal Muscle Mass by Sex. AI, ASM, CI, HA-ASM, NFAI, OR, PA
25  2018 Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening. ARR, EH, PA, PRC
26  2018 Aldosterone-to-renin ratio depends on age and sex in children attending a clinic for cardiovascular risk assessment. ARR, BP, PRC
27  2018 Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays. ARR, CLIA, PA, PRA, PRC
28  2018 Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration. PA, PTX3, UAE
29  2018 Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study. CCT, CI, SIT
30  2018 Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration. ARR
31  2018 Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey. ARR, CCT, PA, SIT
32  2018 Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism. CCT, CI, EH, PA, SIT
33  2018 Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-to-renin ratio with preeclampsia. ARC, ARR, PE
34  2018 Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess. AI, BMD, PA, TBS
35  2018 Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease. ABI, ADPKD, eGFR, LVMI, MRI 3Tesla, TFV, TKV
36  2018 Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data. ARR, DRC, EPATH, GECOH, MR, PA, PHPT, RCT
37  2018 Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease. BP, CKD
38  2018 Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease. ACC, AHA, ASCVD, EH, PA
39  2018 Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio. ARR, BALP, BMD, DXA, PA, PMO, PRC, PTH
40  2018 Prevalence of Somatic KCNJ5 Mutations in Thai Patients With Aldosterone-Producing Adrenal Adenomas. APAs
41  2018 Primary Aldosteronism With Type 2 Diabetes Mellitus Requires More Antihypertensive Drugs for Blood Pressure Control: A Retrospective Observational Study. BP, cBP, DM, PA
42  2018 Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism. APA, PA, VFA
43  2018 Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism. ARR, AVS, PA, SST
44  2018 [Efficacy of Screening and Confirmatory Tests of Primary Aldosteronism in Diagnosing Aldosterone Producing Adenoma]. APA, ARR, AUC, CCT, EH, PA, ROC, SIT
45  2017 ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism. AST, AVS, CCT, CT, FUT, PA, ROC, SIT
46  2017 Aldosterone and renin in cardiac patients referred for catheterization. AF, CAD
47  2017 Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension. AHI, OSA
48  2017 Biventricular Cardiac Hypertrophy in a Patient with Primary Aldosteronism and Atrial Septal Defect. ASD, PRA
49  2017 Case report: schwannoma arising from the unilateral adrenal area with bilateral hyperaldosteronism. ARR, AVS, PRA
50  2017 Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism. AST alone, DS, PA, PA
51  2017 Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock. APACHE, CI, CRP, PRA, SOFA
52  2017 Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population. 25OHD, BP, HTN, PRA, RAAS
53  2017 Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas. ACTH, APAs, BP, PA
54  2017 Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. CCV, nPA
55  2017 Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism. AVS, CST, EH, PA, SIT
56  2017 Relationship and associated mechanisms between ambulatory blood pressure and clinic blood pressure with prevalent cardiovascular disease in diabetic hypertensive patients. ABP, BMI, CBP, CVD
57  2017 Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels. CKD, CrCl, RAASi
58  2017 Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults. BMI, EH, PRA, SUA
59  2016 A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery. APA, AVS, CT, IHA, S-AVS
60  2016 Association between plasma concentration of tolvaptan and urine volume in acute decompensated heart failure patients with fluid overload. ADHF, PRA, TLV
61  2016 Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model. CM, PRA, RAS, TE
62  2016 Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism. BP, EPL, HOMA-IR, MR, PA, PRA, SPL, UAE
63  2016 Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios. ARR, CCT, PA
64  2016 Effects of continuous positive airway pressure therapy on plasma aldosterone levels in patients with obstructive sleep apnea: A meta-analysis. CPAP, OSA, SMD
65  2016 Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial. ---
66  2016 Epicardial Fat Thickness and Primary Aldosteronism. APA, BMI, EAT, LV, LVM, PA, PAC/PRA, PRA, WC
67  2016 Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease. ABI, ABPM, ADPKD, CIMT, eGFR, FMD, Hcy, HOMA-IR, LVMI, MRI, PA, RAAS, RRI
68  2016 On the top of ARB N/L typeCa channel blocker leads to less elevation of aldosterone. ARB, CCB, DBP, L type, PRA, RAS, SBP, UAE
69  2016 Potential effects of age on screening for primary aldosteronism. ARR, AUCs, PA, PRA, YI
70  2016 PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION. BP, OSLT, PA
71  2016 PTH Is a Promising Auxiliary Index for the Clinical Diagnosis of Aldosterone-Producing Adenoma. APA, ARR, CT, NFA, PRA, PTH, RAAS, ROC
72  2016 Relationship between plasma levels of vasoactive mediators and optic nerve head circulation shown by laser speckle flowgraphy. LSFG, MBR, NE, ONH, OPP, PRA
73  2016 Response Prediction and Influence of Tolvaptan in Chronic Heart Failure Patients Considering the Interaction of the Renin-Angiotensin-Aldosterone System and Arginine Vasopressin. AVP, RAAS
74  2016 Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism. ACTH, BAH, MC2R, PA
75  2016 Role of Nox2 and p22phox in Persistent Postoperative Hypertension in Aldosterone-Producing Adenoma Patients after Adrenalectomy. APA, ROS
76  2016 Sodium Infusion Test for Diagnosis of Primary Aldosteronism in Chinese Population. CI, EH, PA, SIT
77  2016 Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24-h urinary aldosterone. AVS, BHA, CI, PA, UHA
78  2016 [An evaluation of plasma aldosterone-to-active-renin ratio in different postures in combination with aldosterone concentration in the diagnosis of aldosteronoma]. ARR, EH
79  2016 [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism]. ARR, AUC-ROC, PA, PRC
80  2015 3beta-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. APA, HSD3B1, qPCR
81  2015 A pilot study of the effects of eplerenone add-on therapy in patients taking renin-angiotensin system blockers. ACEIs, ARBs, BP, EP, PRA, TTKG
82  2015 Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study. LV
83  2015 Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. APA, GFR, MR, PRA
84  2015 Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study. CVD, eGFR, PRA, RAAS, UA
85  2015 Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk. ARR, PTH
86  2015 Plasma aldosterone concentration is positively associated with pulse pressure in patients with primary hypertension. PP
87  2015 The Aldosterone/Renin Ratio as a Diagnostic Tool for the Diagnosis of Primary Hypoaldosteronism in Newborns and Infants. PRA, PRC
88  2015 The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old. ARR, PA, ROC, TAIPAI
89  2015 [The changes in renin-angiotensin-aldosterone-system in different subtypes of Cushing's syndrome]. ACTH, PRA
90  2014 A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population. ARR, PRC, RAAS
91  2014 A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea. CPAP
92  2014 Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension. LV, LVD, MPI, PRA, RAAS, RVD, TDI
93  2014 Aldosterone and glomerular filtration--observations in the general population. ARR, CKD, eGFR
94  2014 Aldosterone-to-renin ratio and nocturnal blood pressure decline assessed by self-measurement of blood pressure at home: the Ohasama Study. ARR, BP, ln, PRA
95  2014 Association of NT-proBNP with plasma renin activity and plasma aldosterone concentration in women with singleton pregnancy. PRA
96  2014 Effects of aliskiren on blood pressure and humoral factors in hypertensive hemodialysis patients previously on angiotensin II receptor antagonists. BNP, BP, DRI, PRA
97  2014 Effects of the T/L-type calcium channel blocker benidipine on albuminuria and plasma aldosterone concentration. A pilot study involving switching from L-type calcium channel blockers to benidipine. BP, CCB, UACR
98  2014 Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage. EH, ICAM-1, LVH, MAU, oxLDL, PA, TOD, vWF
99  2014 Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients. ARB, BP, CCB, LA, LAVI
100  2014 Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. ARR, PRA, PRC